Avenue Therapeutics

$5.93
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.46 (-7.20%) Today

$0.00 (0.00%) As of 9:29 PM UTC after-hours

Why Robinhood?

You can buy or sell ATXI and other stocks, options, and ETFs commission-free!

About ATXI

Avenue Therapeutics, Inc. engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, which is intended for the treatment of moderate to moderately severe post-operative pain. The company was founded on February 9, 2015 and is headquartered in New York, NY. The listed name for ATXI is Avenue Therapeutics, Inc. Common Stock.

CEO

Lucy Lu

Employees

Headquarters

New York, New York

Founded

2015

Market Cap

75.78M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

316.94K

High Today

$6.45

Low Today

$5.75

Open Price

$6.39

Volume

165.77K

52 Week High

$12.34

52 Week Low

$2.85

ATXI Earnings

-$0.43

-$0.29

-$0.14

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 29, After Hours